LOL! NASDAQ that was good.
Of course the Sackler family aka Purdue will be well prepared with Mundipharma. What they loose through the competition with generic OxyContin in the US will be supplemented through sales of OxyContin in countries where there are no restrictions.
More than likely the US based Purdue may start having a harder time, but overall the business for the Sacklers won't break a sweat. They'll just keep pumping their addictive/easily abused Oxy out to other countries under Mundipharma.
What I find interesting is if Elite forms a partnership/JV with PuraCap/HumanWell to sell OxyContin in China. That will also mean competition for Mundipharma in a market Mundi would love to have. China, Mexico, SE Asia, all part of Mundi's strategy (from the Esquire article).
Some interesting stuff coming in the near future.
Companies like Elite could really waffle Purdue's US business though.
When a company builds a better generic mouse trap. that not only works as well, but is cheaper and insurance companies will back..... just stands to reason. Some hurt is gonna come round. Plus SequestOx will also put a dent in Purdue's Oxy since their Oxy is a tweener anyway.
Only gives 8-10 hours of extended relief, not the 12 Purdue claims.
Yep Purdue was top dog..... not for long though. JMO
Really looking forward to Purdue taking some revenue hits.
News 
Market Data 
Discover 
